Product Information
LAMOTRIGINE 5 MG DISPER TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.1673 per EA under NDC 62332009531. Its NADAC has been published 539 times since Jun 8, 2016.
FDA first approved this application on Jun 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332009531
Classification
Generic
Dosage Form
TABLET, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA201168FDA Approved
6/12/2014
TE Code
AB
On Market Since
4/11/2014
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE 5 MG DISPER TABLET has been published 539 times since Jun 8, 2016, and over the history we have for it it has declined 22.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1673 per EA |
|---|---|
| All-time high | $0.3251 (Jan 13, 2021) |
| All-time low | $0.1144 (Feb 20, 2019) |
| 52-week high | $0.1681 |
| 52-week low | $0.1464 |
| Median price | $0.1927 |
| Average price | $0.2063 |
| Largest weekly change | +52.2% (Aug 17, 2016) |
| Weeks tracked | 539 |
| Tracking since | Jun 8, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lamotrigine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE 5 MG DISPER TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE 5 MG DISPER TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.1673 per EA (NDC 62332009531), effective Sep 30, 2026.
How has the price of LAMOTRIGINE 5 MG DISPER TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE 5 MG DISPER TABLET has declined 22.2%. It has been tracked across 539 weekly CMS publications since Jun 8, 2016.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE 5 MG DISPER TABLET?
Since Jun 8, 2016, the NADAC for LAMOTRIGINE 5 MG DISPER TABLET has ranged from a low of $0.1144 (Feb 20, 2019) to a high of $0.3251 (Jan 13, 2021), with a median of $0.1927 per EA.
Are there cheaper alternatives to LAMOTRIGINE 5 MG DISPER TABLET?
No other NADAC-published product currently shares the active ingredient and strength of LAMOTRIGINE 5 MG DISPER TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LAMOTRIGINE 5 MG DISPER TABLET?
LAMOTRIGINE 5 MG DISPER TABLET (NDC 62332009531) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.